The surprisingly strong Boceprevir label reinforces my view in the above post.
I previously thought Telaprevir would outsell Boceprevir by about 4:1 ( http://investorshub.advfn.com/boards/read_msg.aspx?message_id=61399403 ), but I now think it will be more of a dogfight.
Nope....this rings the bell for a buyout offer from one of the big boyz!!!
Good pipeline and now a commercial potential blockbuster for a major illness. Ripe right now before too much earnings to significantly increase the purchase price.
The big boyz need products with patents for major diseases...VRTX NOW is a major target.
All just my $0.02 and that is all it is worth.
I sold at 54.23. I would love a slight correction and welcome it as a buying opportunity.
Hey, Hep C is old news. VRTX is not a one trick pony though.
I profited by two pullbacks and picked up a 100 shares on each.
Let's make it three in a row. Worst case scenario from here is VRTX over 60 at the end of the year. It's heavily institutionally owned and some those big boys may want to take some profit.
They sell and then come back.
Dew has been wrong (negative) about vrtx for a long time and he has been proven wrong at every turn. He also was the one who hyped IDIX and a lot of his followers' includding yours truely' lost lots of money because he always talked with an aura of authority like he knew what he was talking about and so many of us followed mosrt of his pronouncements. Many of us learned the hard way that he thinks he knows a lot but he really does not. Follow him to your own peril!!!